SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories sells balance stake in Optimus Drugs

05 Dec 2023 Evaluate

Unichem Laboratories has sold balance 4918 equity shares representing 0.02% holding in Optimus Drugs to Sekhmet Pharmaventures for an aggregate consideration of Rs 67.47 crore. In May 2022, the company sold 19.97% of equity shares of Optimus to Sekhmet Pharmaventures on a fully diluted basis in the first tranche, for an aggregate consideration of Rs 270.99 crore.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

375.00 -9.75 (-2.53%)
24-Apr-2026 10:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1627.50
Dr. Reddys Lab 1311.00
Cipla 1289.45
Zydus Lifesciences 927.75
Lupin 2299.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×